← Back to BCTX

BriaCell Therapeutics Corp. - Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSApr 2026Filed 09/06/2026Jan 2026Filed 10/03/2026Oct 2025Filed 11/12/2025Apr 2025Filed 09/06/2026Jan 2025Filed 10/03/2026Oct 2024Filed 11/12/2025Apr 2024Filed 16/06/2025Jan 2024Filed 12/03/2025
−$7.2−$7.2−$8.2−$6.1−$6.3−$5.8$1.7−$11
−$0.99−$2.58−$4.35−$16.42−$23.31−$32.67$1.61−$10.64
7.32.81.90.40.31.11.1

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.